You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Low-dose oral psoralen photochemotherapy (PUVA) and ultraviolet-B (UVB) therapy significantly reduced rash and itch in polymorphic light eruption (PLE) patients. These treatments offered protection against increasing ultraviolet radiation exposure compared to controls.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: